Studies on the mechanism maintaining biconcave shape of human erythrocytes.
D000251:Adenosine Triphosphatases; D002104:Cadmium / Q000494:pharmacology; D002473:Cell Wall / Q000378:metabolism; D002614:Chelating Agents; D003035:Cobalt / Q000494:pharmacology; D003300:Copper / Q000494:pharmacology; D004912:Erythrocytes / Q000166:cytology* / Q000201:enzymology; D005459:Fluorides / Q000494:pharmacology; D006801:Humans; D007461:Iodoacetates / Q000494:pharmacology; D008628:Mercury / Q000494:pharmacology; D009532:Nickel / Q000494:pharmacology; D009941:Organomercury Compounds / Q000494:pharmacology; D009996:Osmotic Fragility; D010042:Ouabain; D010206:Papain; D011188:Potassium / Q000378:metabolism; D012834:Silver / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D014357:Trypsin; D015032:Zinc / Q000494:pharmacology
D002614:Chelating Agents; D007461:Iodoacetates; D009941:Organomercury Compounds; D002104:Cadmium; D003035:Cobalt; D012834:Silver; D010042:Ouabain; D003300:Copper; D009532:Nickel; D012964:Sodium; D014357:Trypsin; D010206:Papain; D000251:Adenosine Triphosphatases; D008628:Mercury; D015032:Zinc; D005459:Fluorides; D011188:Potassium